David Wiadrowski, a director at $LIF, sold 5,957 shares of the company on 03-13-2026 for an estimated $246,262. We received data on the trade from a recent SEC filing. This was a sale of approximately 13.1% of their shares of this class of stock. Following this trade, they now own 39,679 shares of this class of $LIF stock.
$LIF Insider Trading Activity
$LIF insiders have traded $LIF stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $LIF stock by insiders over the last 6 months:
- CHRIS HULLS has made 0 purchases and 7 sales selling 433,595 shares for an estimated $33,598,132.
- ALEX HARO has made 0 purchases and 4 sales selling 101,887 shares for an estimated $7,765,196.
- LAUREN ANTONOFF (Chief Executive Officer) has made 0 purchases and 5 sales selling 50,233 shares for an estimated $3,482,103.
- CHARLES J. PROBER has made 0 purchases and 5 sales selling 39,650 shares for an estimated $2,789,853.
- MARK GOINES sold 15,000 shares for an estimated $1,112,850
- JOHN PHILIP COGHLAN has made 0 purchases and 6 sales selling 9,375 shares for an estimated $879,770.
- JAMES SYNGE has made 0 purchases and 2 sales selling 3,966 shares for an estimated $253,662.
- DAVID WIADROWSKI sold 5,957 shares for an estimated $246,262
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LIF Hedge Fund Activity
We have seen 122 institutional investors add shares of $LIF stock to their portfolio, and 118 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 563,316 shares (+21.6%) to their portfolio in Q4 2025, for an estimated $36,131,088
- LORD, ABBETT & CO. LLC removed 519,342 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $33,310,595
- INVESCO LTD. removed 407,268 shares (-91.5%) from their portfolio in Q4 2025, for an estimated $26,122,169
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 354,173 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $22,716,656
- MARSHALL WACE, LLP removed 341,563 shares (-85.3%) from their portfolio in Q4 2025, for an estimated $21,907,850
- GREENSPRING ADVISORS, LLC added 338,637 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,720,177
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 325,955 shares (+3033.0%) to their portfolio in Q4 2025, for an estimated $20,906,753
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LIF Revenue
$LIF had revenues of $146M in Q4 2025.
You can track LIF financials on Quiver Quantitative's LIF stock page.
$LIF Analyst Ratings
Wall Street analysts have issued reports on $LIF in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 12/16/2025
- DA Davidson issued a "Buy" rating on 12/12/2025
- UBS issued a "Buy" rating on 11/11/2025
To track analyst ratings and price targets for $LIF, check out Quiver Quantitative's $LIF forecast page.
$LIF Price Targets
Multiple analysts have issued price targets for $LIF recently. We have seen 6 analysts offer price targets for $LIF in the last 6 months, with a median target of $86.75.
Here are some recent targets:
- Stephen Ju from UBS set a target price of $75.0 on 03/03/2026
- Maria Ripps from Canaccord Genuity set a target price of $94.0 on 03/03/2026
- Mark Kelley from Stifel set a target price of $76.0 on 01/27/2026
- Ronald Josey from Citigroup set a target price of $79.5 on 01/09/2026
- Wyatt Swanson from DA Davidson set a target price of $94.0 on 12/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
